Keyword Analysis & Research: pembrolizumab bevacizumab cervical cancer
Keyword Analysis
| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| pembrolizumab bevacizumab cervical cancer | 1.84 | 0.2 | 3828 | 46 | 41 |
| pembrolizumab | 0.13 | 0.8 | 2932 | 39 | 13 |
| bevacizumab | 0.21 | 0.7 | 2395 | 49 | 11 |
| cervical | 0.97 | 0.5 | 3893 | 15 | 8 |
| cancer | 0.52 | 0.2 | 8691 | 35 | 6 |
Keyword Research: People who searched pembrolizumab bevacizumab cervical cancer also searched
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| pembrolizumab bevacizumab cervical cancer | 0.43 | 0.7 | 4437 | 7 |
| pembrolizumab cervical cancer uk | 1.83 | 0.9 | 2574 | 26 |
| pembrolizumab cervical cancer approval | 0.14 | 0.5 | 8545 | 76 |
| pembrolizumab cervical cancer ema | 0.11 | 0.4 | 5164 | 19 |
| metastatic cervical cancer pembrolizumab | 1.11 | 0.9 | 1906 | 3 |
| fda approval pembrolizumab cervical cancer | 0.12 | 0.6 | 2278 | 67 |
| nice pembrolizumab cervical cancer | 1.27 | 0.2 | 1552 | 80 |
| pembrolizumab for head and neck cancer | 0.61 | 0.3 | 4294 | 65 |
| bevacizumab and pembrolizumab glioblastoma | 0.7 | 0.5 | 409 | 65 |
| pembrolizumab for cancer patients | 1.98 | 0.6 | 4537 | 88 |
| pembrolizumab head and neck cancer nejm | 1.56 | 0.8 | 9312 | 89 |
| pembrolizumab for breast cancer | 0.58 | 0.6 | 7352 | 18 |
| pembrolizumab adjuvant breast cancer | 0.63 | 0.3 | 6967 | 99 |
| pembrolizumab cancer research uk | 0.6 | 0.1 | 8049 | 7 |
| pembrolizumab for colon cancer | 0.73 | 0.4 | 7903 | 91 |
| pembrolizumab breast cancer approval | 1.3 | 0.4 | 2758 | 36 |
| pembrolizumab a chemo drug | 1.77 | 0.2 | 2456 | 80 |
